PamelaBarbaglia
Stories by PamelaBarbaglia
Turkish owner of Godiva chocolate Yildiz exploring sale of Japanese business
Godiva's Japanese business has revenue of around $350 million a year and is likely to appeal to companies or investors with experience in Japan.
Nestle, Unilever, Coke place bids for over $4b GSK India business
The three consumer goods giants are seen as frontrunners for a business that offers a significant footprint in a fast-growing emerging market.
GSK seeks mid-Sept bids for $4b Horlicks unit in India
The main asset on the block in the sale is GSK's 72.5% stake in its Indian subsidiary GlaxoSmithKline Consumer Healthcare, which is famous for Horlic
Saudi Arabia’s PIF said to have evinced no interest in financing Tesla buyout
PIF's reluctance will add to the pressure on Musk to produce details of his financing plan.
Italy’s Benettons tap GIC among bidders for Cellnex holding vehicle
Singapore’s sovereign wealth fund GIC and other infrastructure funds are said to be interested in Cellnex due to its high growth rate, resilient bus
Mubadala’s talks to sell Swiss arm hit snag due to 1MDB links
The business, Falcon Private Bank, is under investigation in Switzerland for allegedly failing to prevent suspected money laundering linked to 1MDB, t
Temasek, CVC seek buyers for generics firm Alvogen’s eastern European ops
Alvogen’s central and eastern European (CEE) business may be valued at up to $1 billion. CVC and Temasek bought a controlling stake in Alvogen in 20
Global M&A boosts confidence as it reaches record high in Q1
While the value of M&A deals globally increased 67 percent year-on-year in the first quarter of 2018, the number of deals dropped by 10 percent to 10,
Imagination investors approve $730m sale to China-backed Canyon Bridge
Canyon's founder Benjamin Chow was charged on Monday with insider trading in a case related to the attempted U.S. deal.
Minimum of three bidders seen advancing in Unilever spreads unit auction
Buyout funds Blackstone and CVC Capital, who were teaming up on a joint offer, are no longer in the running.
